Delays to Low-Risk Thyroid Cancer Treatment During COVID-19

JAMA Otolaryngology–Head & Neck Surgery

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, OCTOBER 29, 2020

Media advisory: The full article is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/10.1001/jamaoto.2020.3878?guestAccessKey=94e33eac-1e63-422f-a783-5efcd6aebb17&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=102920

 

What The Article Says: This Viewpoint examines the potential benefits that delaying low-risk thyroid surgical procedures may provide for patients as the COVID-19 pandemic continues to alter treatment timelines.

Authors: Brooke Nickel, M.I.P.H., Ph.D., of the University of Sydney in Australia, is the corresponding author.

 

(doi:10.1001/jamaoto.2020.3878)

Editor’s Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.